About
Magneto is developing innovative thrombectomy solutions for the removal of blood clots in the vascular system.
The Magneto catheters use electric fields to create an attraction with the target clot. When voltage is applied, the negatively charged ions of the clot are bonded to the active positive electrode of the catheter, creating a strong magnetic type of grip. This allows for clot removal without damaging the endoluminal surface of the vessel while lessening the chance of distal embolization. The fibrin content of a blood clot possesses high charge electrical density enabling strong adherence. Magneto's technology has been proven to be effective for all clot types - from acute- soft, red, Red Blood Cell-rich clots to chronic- firm, white, fibrin-rich clots. In-vitro tests have shown success in addressing a wide range of clot types with this proprietary technology.
The eTrieve™ PE kit is custom designed for the pulmonary arteries. Using Magneto's large bore aspiration catheter, together with the eTrieve™ Catheter with its proprietary electric attachment technology, the system can remove both proximal and distal emboli with minimal artery interaction and less fragmentation.
The company has demonstrated the safety and efficacy of its eTrieve PE Kit with its successful first-in-human (FIH) study. The results showed a significant reduction in right ventricular to left ventricular diameter (RV/LV) ratio and alleviation of symptoms associated with PE.